Biotechnology News

REYKJAVIK, Iceland, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...

REYKJAVIK, ICELAND (August 21, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...

Reykjavík (21. ágúst 2026) — Alvotech tilkynnti í dag að félagið hefði gert samstarfssamning við lyfjafyrirtækið Lotus Pharmaceutical um markaðssetningu í Bandaríkjunum og nokkrum Asíuríkjum á tveimur...

SAN DIEGO, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics...

Proposed merger to create a Nasdaq-listed, late-stage biotechnology company advancing neridronate, a potential first FDA-approved treatment for CRPS-1, a debilitating orphan disease with 65,000 newly...

PharmAla Biotech provides a corporate update relating to its investment banking partner, Canaccord Genuity LLC, and its IP.

National Institute for Health and Care Excellence guidance supports NHS funding and wider patient access to life-saving organ transplantation technology

COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results and business progress for the second quarter and first half of 2026 and released...

KØBENHAVN, Danmark, 21. august 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggjorde i dag sine delårsresultater og den forretningsmæssige udvikling for andet kvartal og første halvår af 2026 samt...

Repurchased shares will be subject to cancellation, pending shareholder resolution COPENHAGEN, Denmark, August 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced its plans to launch a new...